Talk:Enzymotec

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

some content[edit]

stashing this here

Their PS-soy product had received GRAS clearance from the US FDA in December 2007[1] and from the European Union in 2011[2] Enzymotec received GRAS clearance from the FDA to market "Sharp PS Green" - a PS derived from sunflower, in June 2015.[3]

In 2007 they received approval in Europe to market their PS-based "CardiaBeat" product to promote heart health.[4]

In January 2016 Enzymotec began marketing its "Sharp PS" ingredient, a phosphatidylserine (PS) derived from soy, for sports nutrition; it had already been marketing Sharp PS for age-related memory loss.[5] In April 2016 it rebranded its line of PS products as "EnzyPS' and started marketing them in skin health, stress reduction, and mood enhancement.[6]

References

  1. ^ "GRAS 223: Phosphatidylserine derived from soy" (PDF). FDA. May 22, 2007. See index page at FDA website: GRN No 223
  2. ^ "Commission Implementing Decision (2011/513/EU)". Official Journal of the European Union. L 215/20. August 20, 2011.
  3. ^ "GRAS 545: Phosphatidylserine derived from sunflower" (PDF). FDA. Oct 10, 2014.. See index page at FDA website: GRN No 545
  4. ^ McNally, Alex (December 11, 2007). "Enzymotec's CardiaBeat delves deeper into Europe". Nutra Ingredidents.
  5. ^ Dinkovski, Noli (January 19, 2016). "Enzymotec unveils phosphatidylserine-based sports enhancer". Food Manufacture.
  6. ^ "Enzymotec: PS The Next Big Thing in Nutraceuticals". Nutrition Insight. April 28, 2016.

-- Jytdog (talk) 03:52, 20 September 2016 (UTC)[reply]

sources[edit]

(copied from Talk:Vayarin)

searched for high quality sources...

  • there are no reviews on Vayarin in pubmed from the last five years, per this.
  • there are no reviews on Vayarin in pubmed at all, per this
  • there are no reviews on Lipirinen in pubmed per this
  • no mention of lipirinen on fda website per this
  • one mention of Vayarin on fda website per this; that one hit is this GRAS notification from ECA Healthcare about phosphatidylserine from fish lecithin; (their tradename, "DHAPS").
  • Searched FDA website for enzymotec and found four GRAS notifications from enzymotec:
    • GRN 223: Phosphatidylserine; Intended use - Ingredient in milk, flavored milk, milk drinks (excluding milk, fluid), milk imitation (soy milk), milk-based meal replacement, yogurt, breakfast bars and fruit flavored drink at levels of 100 milligrams (mg) phosphatidylserine per serving and in breakfast cereals and milk (fluid) at 50 mg/serving. Enzymotec Ltd., Israel. Date of closure - December 20, 2007. http://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=223. Marketed per this as "Sharp-PS".
    • GRN 279: Phosphatidylserine derived from fish; Intended use - Ingredient in breakfast cereals, dairy product analogs, grain products and pastas, milk products and processed fruits and fruit juices at levels intended to provide 30 mg of phosphatidylserine per serving; and as an ingredient of medical foods at levels that would not exceed 300 mg of phosphatidylserine per day. Enzymotec Ltd., Israel. Date of closure - July 29, 2009. http://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=279. (per this not branded when they submitted)
    • GRN 311: Krill-based phosphatidylserine; Intended use - Ingredient in breakfast cereals, dairy product analogs, grain products and pastas, milk products and processed fruits and fruit juices at a use level intended to provide 30 mg of phosphatidylserine per serving; and as an ingredient in medical foods at levels that would not exceed 300 mg of phosphatidylserine per day. Enzymotec Ltd., Israel. Date of closure – June 15, 2010. http://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=311. per this not branded when they submitted
    • GRN 545: Phosphatidylserine derived from sunflower; Intended use – same as GRN 223 except medical foods. Intended for use in milk, flavored milk, milk drinks (excluding milk, fluid), milk imitation (soy milk), milk-based meal replacement, yogurt, breakfast bars and fruit flavored drink at levels of 100 mg PS per serving; in breakfast cereals and milk (fluid) at 50 mg/serving; and in medical foods at levels not to exceed 300 mg/serving. Enzymotec Ltd., Israel. Date of closure – June 5, 2015. http://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=545.

just to be sure checked

So none.

Less good sources - science-oriented popular media

-- OK then. Jytdog (talk) 22:31, 19 September 2016 (UTC)[reply]